Review of current classification, molecular alterations, and tyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophilia

por Havelange, Violaine, Demoulin, Jean-Baptiste
Publicado 2013

Case report: Chronic neutrophilic leukemia associated with monoclonal gammopathies. A case series and review of genetic characteristics and practical management

por Vermeersch, Gaël, Delforge, Michel, Havelange, Violaine, Graux, Carlos, Michaux, Lucienne, Devos, Timothy
Publicado 2022

Recent advances in therapies for primary myelofibrosis

por Vainchenker, William, Yahmi, Nasrine, Havelange, Violaine, Marty, Caroline, Plo, Isabelle, Constantinescu, Stefan N
Publicado 2023

MiR-15a-5p Confers Chemoresistance in Acute Myeloid Leukemia by Inhibiting Autophagy Induced by Daunorubicin

por Bollaert, Emeline, Claus, Melissa, Vandewalle, Virginie, Lenglez, Sandrine, Essaghir, Ahmed, Demoulin, Jean-Baptiste, Havelange, Violaine
Publicado 2021

miR‐15a‐5p and miR‐21‐5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2

por Vandewalle, Virginie, Essaghir, Ahmed, Bollaert, Emeline, Lenglez, Sandrine, Graux, Carlos, Schoemans, Hélène, Saussoy, Pascale, Michaux, Lucienne, Valk, Peter J. M., Demoulin, Jean‐Baptiste, Havelange, Violaine
Publicado 2020

Association between severe acute malnutrition in childhood and hematological disorders in adulthood: the Lwiro follow-up study in the Eastern Democratic Republic of the Congo

por Bedha, Aline, Shindano, Tony, Hermans, Michel P., Havelange, Violaine, Makali, Samuel, Minani, Jimmy, Ngaboyeka, Gaylord, Kunaba, Edwige, Donnen, Philippe, Dramaix, Michelle, Bisimwa, Ghislain, Mwene-Batu, Pacifique
Publicado 2023

Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosis

por Lecomte, Sara, Devreux, Julien, de Streel, Grégoire, van Baren, Nicolas, Havelange, Violaine, Schröder, David, Vaherto, Noora, Vanhaver, Christophe, Vanderaa, Christophe, Dupuis, Noémie, Pecquet, Christian, Coulie, Pierre G., Constantinescu, Stefan N., Lucas, Sophie
Publicado 2023

Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia

por Ngankeu, Apollinaire, Ranganathan, Parvathi, Havelange, Violaine, Nicolet, Deedra, Volinia, Stefano, Powell, Bayard L., Kolitz, Jonathan E., Uy, Geoffrey L., Stone, Richard M., Kornblau, Steven M., Andreeff, Michael, Croce, Carlo M., Bloomfield, Clara D., Garzon, Ramiro
Publicado 2017

Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice—data from a Belgian registry

por Devos, Timothy, Havelange, Violaine, Theunissen, Koen, Meers, Stef, Benghiat, Fleur Samantha, Gadisseur, Alain, Vanstraelen, Gaëtan, Vellemans, Hélène, Bailly, Benjamin, Granacher, Nikki, Lewalle, Philippe, De Becker, Ann, Van Eygen, Koen, Janssen, Mia, Triffet, Agnes, Vrelust, Inge, Deeren, Dries, Mazure, Dominiek, Bekaert, Julie, Beck, Michael, Selleslag, Dominik
Publicado 2021

Prognostic Value of FLT3-Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia

por Grob, Tim, Sanders, Mathijs A., Vonk, Christian M., Kavelaars, Franҫois G., Rijken, Melissa, Hanekamp, Diana W., Gradowska, Patrycja L., Cloos, Jacqueline, Fløisand, Yngvar, van Marwijk Kooy, Marinus, Manz, Markus G., Ossenkoppele, Gert J., Tick, Lidwine W., Havelange, Violaine, Löwenberg, Bob, Jongen-Lavrencic, Mojca, Valk, Peter J.M.
Publicado 2023

Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3(mut+) AML ineligible for intensive chemotherapy

por Wang, Eunice S., Montesinos, Pau, Minden, Mark D., Lee, Je-Hwan, Heuser, Michael, Naoe, Tomoki, Chou, Wen-Chien, Laribi, Kamel, Esteve, Jordi, Altman, Jessica K., Havelange, Violaine, Watson, Anne-Marie, Gambacorti-Passerini, Carlo, Patkowska, Elzbieta, Liu, Shufang, Wu, Ruishan, Philipose, Nisha, Hill, Jason E., Gill, Stanley C., Rich, Elizabeth Shima, Tiu, Ramon V.
Publicado 2022

Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms

por Pecquet, Christian, Papadopoulos, Nicolas, Balligand, Thomas, Chachoua, Ilyas, Tisserand, Amandine, Vertenoeil, Gaëlle, Nédélec, Audrey, Vertommen, Didier, Roy, Anita, Marty, Caroline, Nivarthi, Harini, Defour, Jean-Philippe, El-Khoury, Mira, Hug, Eva, Majoros, Andrea, Xu, Erica, Zagrijtschuk, Oleh, Fertig, Tudor E., Marta, Daciana S., Gisslinger, Heinz, Gisslinger, Bettina, Schalling, Martin, Casetti, Ilaria, Rumi, Elisa, Pietra, Daniela, Cavalloni, Chiara, Arcaini, Luca, Cazzola, Mario, Komatsu, Norio, Kihara, Yoshihiko, Sunami, Yoshitaka, Edahiro, Yoko, Araki, Marito, Lesyk, Roman, Buxhofer-Ausch, Veronika, Heibl, Sonja, Pasquier, Florence, Havelange, Violaine, Plo, Isabelle, Vainchenker, William, Kralovics, Robert, Constantinescu, Stefan N.
Publicado 2023

Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial

por Rijneveld, Anita W., van der Holt, Bronno, de Weerdt, Okke, Biemond, Bart J., van de Loosdrecht, Arjen A., van der Wagen, Lotte E., Bellido, Mar, van Gelder, Michel, van der Velden, Walter J. F. M., Selleslag, Dominik, van Lammeren-Venema, Daniëlle, Halkes, Constantijn J. M., Fijnheer, Rob, Havelange, Violaine, van Sluis, Geerte L., Legdeur, Marie-Cecile, Deeren, Dries, Gadisseur, Alain, Sinnige, Harm A. M., Breems, Dimitri A., Jaspers, Aurélie, Legrand, Ollivier, Terpstra, Wim E., Boersma, Rinske S., Mazure, Dominiek, Triffet, Agnes, Tick, Lidwine W., Beel, Karolien, Maertens, Johan A., Beverloo, H. Berna, Bakkus, Marleen, Homburg, Christa H. E., de Haas, Valerie, van der Velden, Vincent H. J., Cornelissen, Jan J.
Publicado 2022